Reporting owner · CIK 0001801917

Venker Eric

Visual SEC Form 4 history across 1 companies, 22 transactions and 6 filings.

PRES, ICPresident & Immunovant CEORoivant Sciences Ltd.
Open-market mix
Latest filingSep 02, 2026, 01:00 AM
Filings6Form 4 records
Buying$00 purchases
Selling$18.3M7 sales
Net value−$18.3MBuys minus sells
Companies12 securities
Most recentAug 28, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-51Jan 253Feb 251Jan 262Aug 26

Net value flow

Buys minus sells

Jan 25
−$1.1M
Feb 25
−$5.6M
Jan 26
−$4.4M
Aug 26
−$7.2M

Transaction texture

Ownership and ticket size

Average P/S size$2.6M
Median P/S size$2.3M
Direct22
Indirect0
Aug 28, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern3Derivative Transactionfiling-context6Direct Ownershipfiling-context22Large Holdings Increaseholdings2Large Holdings Reductionholdings1Large Salesize7Repeat Sellerpattern410b5-1 Detectedfiling-context8

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Roivant Sciences Ltd. on Aug 28, 2026 valued at $1,232,328.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Roivant Sciences Ltd. on Aug 28, 2026 valued at $1,232,328.

Review SEC filing

Associated companies

Visual map of known reporting history

ROIVRoivant Sciences Ltd.22 transactions · latest Sep 02, 2026, 01:00 AM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
ROIVVenker Eric
PRESIC
exercise10b5-1200k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
0.0%09/0208/28
ROIVVenker Eric
PRESIC
sale10b5-133.8k-$123MS
Cluster Selling Direct Ownership Large Sale+2
0.0%09/0208/28
ROIVVenker Eric
PRESIC
sale10b5-1166k-$592MS
Cluster Selling Direct Ownership Large Sale+1
0.0%09/0208/28
ROIVVenker Eric
PRESIC
exercise10b5-1200k$77.0MM
Direct Ownership 10b5-1 Detected
0.0%09/0208/28
ROIVVenker Eric
PRESIC
withholding13.9k-$51.2MF
Direct Ownership
0.0%08/2508/20
ROIVVenker Eric
PRESIC
exercise200k$0M
Derivative Transaction Direct Ownership
—01/1501/12
ROIVVenker Eric
PRESIC
sale200k-$438MS
Direct Ownership Large Sale
—01/1501/12
ROIVVenker Eric
PRESIC
exercise200k$77.0MM
Direct Ownership
—01/1501/12
ROIVVenker Eric
PRESCOO
exercise100k$0M
Derivative Transaction Direct Ownership
—02/25/202502/20/2025
ROIVVenker Eric
PRESCOO
withholding10.9k-$11.7MF
Direct Ownership
—02/25/202502/20/2025

Venker Eric Insider Activity FAQ

SEC Form 4 context

Who is Venker Eric?

Venker Eric is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001801917.

Which companies has Venker Eric reported transactions for?

Roivant Sciences Ltd.

When was Venker Eric's latest insider buy?

No open-market insider purchase is available for this period.

When was Venker Eric's latest insider sale?

sale at Roivant Sciences Ltd. on Aug 28, 2026 valued at $1,232,328.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.